ARROWHEAD PHARMACEUTICALS, INC. Other Current Assets
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Other Current Assets of $35.52 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-04
- 2026-06-30: Other Assets, Current $35.52M.
- 2026-03-31: Other Assets, Current $18.25M.
- 2025-12-31: Other Assets, Current $22.86M.
- 2025-09-30: Other Assets, Current $13.52M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $35.52M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $18.25M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $22.86M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $13.52M 10-Q · filed 2026-08-04 | |
| 2025-06-30 | $13.16M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $11.68M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $5.74M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $4.97M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $4.18M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $7.51M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $7.10M 10-Q · filed 2024-02-06 | |
| 2023-09-30 | $4.03M 10-K · filed 2024-11-26 | $7.08M 10-K · filed 2023-11-29 |
| 2023-06-30 | $7.16M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $14.44M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $25.19M 10-Q · filed 2023-02-06 | |
| 2022-09-30 | $20.20M 10-K · filed 2023-11-29 | |
| 2022-06-30 | $8.89M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $7.80M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.79M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $2.19M 10-K · filed 2022-11-28 | |
| 2021-06-30 | $1.70M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.84M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $2.32M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $1.78M 10-K · filed 2021-11-22 | $1.78M 10-K · filed 2020-11-23 |
| 2020-06-30 | $2.41M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.54M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.53M 10-Q · filed 2020-02-05 | |
| 2019-09-30 | $2.56M 10-K · filed 2020-11-23 | |
| 2019-06-30 | $1.49M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $1.59M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $478.31K 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $640.12K 10-K · filed 2019-11-25 | |
| 2018-06-30 | $279.05K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $357.99K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.60M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $1.36M 10-K · filed 2018-12-11 | |
| 2017-06-30 | $896.15K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.75M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $3.50M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $3.77M 10-K · filed 2017-12-12 | |
| 2016-06-30 | $1.51M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $909.56K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.90M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $823.62K 10-K · filed 2016-12-14 | |
| 2015-06-30 | $654.92K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $327.38K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $62.84K 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $48.50K 10-K · filed 2015-12-14 | |
| 2014-06-30 | $538.74K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $633.81K 10-Q · filed 2014-05-06 | |
| 2013-09-30 | $91.66K 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |